TASS3y
Over 90% inoculated with EpiVacCorona jab developed COVID-19 antibodies, says researcher
EpiVacCorona, developed by the Russian sanitary watchdog’s State Research Center of Virology and Biotechnology Vector, is Russia’s second coronavirus vaccine MOSCOW, May 5. /TASS/. More than ...
BioSpace1d
Vir Leans Into Immunology Roots After Flamed-Out COVID Fame
Just a few months after Vir Biotechnology lost an emergency authorization for its COVID-19 antibody, Marianne de Backer ...
FiercePharma3d
Novartis debuts €40M viral vector plant in Slovenia, part of €3.5B investment push in the country
Amid a broader push to beef up cell and gene therapy manufacturing capacity in Europe, Novartis has opened the doors to a €40 ...
Baylor College of Medicine4y
Vector Biology and Bacterial Pathogens Lab
This project builds on recent work reporting tick transmission of relapsing fever spirochetes and genome sequencing of both the pathogen and tick vector. We have utilized both next generation and ...
Business Wire15h
Prolific Machines Announces the Appointment of Former Forge Biologics Executive, Christina Perry, as CFO Setting the Stage for Optogenetics Leader’s Biopharmaceutical ...
Prolific Machines, a biotechnology innovator unlocking unprecedented cellular control with light, appoints Christina Perry as CFO.
TASS4y
Russia’s Vector Institute to begin clinical trials of COVID-19 vaccine in late June - CEO
MOSCOW, May 26. /TASS/. The Vector State Center for Virology and Biotechnology (Vector Institute) plans to begin clinical trials of its coronavirus vaccine in late June this year, the Center’s ...